FilingSEC EDGAR6-K
Evogene Receives Additional 180-Day Period from Nasdaq to Regain Minimum Bid Price Compliance
· SEC accepted
StageCompliance extension granted
Filing content
The company has been granted an extension until March 29, 2027, to meet Nasdaq's minimum bid price requirement and may consider options such as a reverse stock split if necessary.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…